174 related articles for article (PubMed ID: 18158768)
101. Selenium-doped calcium carbonate nanoparticles loaded with cisplatin enhance efficiency and reduce side effects.
Zhao P; Li M; Chen Y; He C; Zhang X; Fan T; Yang T; Lu Y; Lee RJ; Ma X; Luo J; Xiang G
Int J Pharm; 2019 Oct; 570():118638. PubMed ID: 31449842
[TBL] [Abstract][Full Text] [Related]
102. Cisplatin-Rich Polyoxazoline-Poly(aspartic acid) Supramolecular Nanoparticles.
Zhang P; Yuan K; Li C; Zhang X; Wu W; Jiang X
Macromol Biosci; 2017 Dec; 17(12):. PubMed ID: 29068544
[TBL] [Abstract][Full Text] [Related]
103. Quercetin Remodels the Tumor Microenvironment To Improve the Permeation, Retention, and Antitumor Effects of Nanoparticles.
Hu K; Miao L; Goodwin TJ; Li J; Liu Q; Huang L
ACS Nano; 2017 May; 11(5):4916-4925. PubMed ID: 28414916
[TBL] [Abstract][Full Text] [Related]
104. Synthesis and characterisation of arsenic nanoparticles and its interaction with DNA and cytotoxic potential on breast cancer cells.
Subastri A; Arun V; Sharma P; Preedia Babu E; Suyavaran A; Nithyananthan S; Alshammari GM; Aristatile B; Dharuman V; Thirunavukkarasu C
Chem Biol Interact; 2018 Nov; 295():73-83. PubMed ID: 29277637
[TBL] [Abstract][Full Text] [Related]
105. [Application and advancement of magnetic iron-oxide nanoparticles in tumor-targeted therapy].
Chen Y; Chen BA
Chin J Cancer; 2010 Jan; 29(1):125-8. PubMed ID: 20038325
[TBL] [Abstract][Full Text] [Related]
106. Intracellular drug delivery of layered double hydroxide nanoparticles.
Oh JM; Park CB; Choy JH
J Nanosci Nanotechnol; 2011 Feb; 11(2):1632-5. PubMed ID: 21456254
[TBL] [Abstract][Full Text] [Related]
107. Immunotoxicity and biodistribution analysis of arsenic trioxide in C57Bl/6 mice following a 2-week inhalation exposure.
Burchiel SW; Mitchell LA; Lauer FT; Sun X; McDonald JD; Hudson LG; Liu KJ
Toxicol Appl Pharmacol; 2009 Dec; 241(3):253-9. PubMed ID: 19800901
[TBL] [Abstract][Full Text] [Related]
108. Nanomedicine-based combination of gambogic acid and retinoic acid chlorochalcone for enhanced anticancer efficacy in osteosarcoma.
Liu L; Qi XJ; Zhong ZK; Zhang EN
Biomed Pharmacother; 2016 Oct; 83():79-84. PubMed ID: 27470553
[TBL] [Abstract][Full Text] [Related]
109. Arsenic trioxide liposome gels for the treatment of psoriasis in mice.
Liu L; Ji F; Zhao Y; Hai X
J Liposome Res; 2024 Jun; 34(2):264-273. PubMed ID: 37621197
[TBL] [Abstract][Full Text] [Related]
110. Nutlin-3 treatment spares cisplatin-induced inhibition of bone healing while maintaining osteosarcoma toxicity.
Stine KC; Wahl EC; Liu L; Skinner RA; VanderSchilden J; Bunn RC; Montgomery CO; Aronson J; Becton DL; Nicholas RW; Swearingen CJ; Suva LJ; Lumpkin CK
J Orthop Res; 2016 Oct; 34(10):1716-1724. PubMed ID: 26867804
[TBL] [Abstract][Full Text] [Related]
111. Convertible MRI contrast: Sensing the delivery and release of anti-glioma nano-drugs.
Zhang L; Zhang Z; Mason RP; Sarkaria JN; Zhao D
Sci Rep; 2015 May; 5():9874. PubMed ID: 25962872
[TBL] [Abstract][Full Text] [Related]
112. Targeted Mesoporous Silica Nanoparticles Delivering Arsenic Trioxide with Environment Sensitive Drug Release for Effective Treatment of Triple Negative Breast Cancer.
Wu X; Han Z; Schur RM; Lu ZR
ACS Biomater Sci Eng; 2016 Apr; 2(4):501-507. PubMed ID: 33465854
[TBL] [Abstract][Full Text] [Related]
113. Surface engineering of nanoparticles with ligands for targeted delivery to osteosarcoma.
Huang X; Wu W; Yang W; Qing X; Shao Z
Colloids Surf B Biointerfaces; 2020 Jun; 190():110891. PubMed ID: 32114271
[TBL] [Abstract][Full Text] [Related]
114. Impact of magnetic nanoparticles in biomedical applications.
Naqvi S; Samim M; Dinda AK; Iqbal Z; Telagoanker S; Ahmed FJ; Maitra A
Recent Pat Drug Deliv Formul; 2009 Jun; 3(2):153-61. PubMed ID: 19519575
[TBL] [Abstract][Full Text] [Related]
115. Fabrication of water-soluble polymer-encapsulated As4S4 to increase oral bioavailability and chemotherapeutic efficacy in AML mice.
Ma Q; Wang C; Li X; Guo H; Meng J; Liu J; Xu H
Sci Rep; 2016 Jul; 6():29348. PubMed ID: 27383126
[TBL] [Abstract][Full Text] [Related]
116. Highly magnetic core-shell nanoparticles with a unique magnetization mechanism.
Yoon TJ; Lee H; Shao H; Weissleder R
Angew Chem Int Ed Engl; 2011 May; 50(20):4663-6. PubMed ID: 21495138
[No Abstract] [Full Text] [Related]
117. Drug delivery without nanoparticle uptake: delivery by a kiss-and-run mechanism on the cell membrane.
Hofmann D; Messerschmidt C; Bannwarth MB; Landfester K; Mailänder V
Chem Commun (Camb); 2014 Feb; 50(11):1369-71. PubMed ID: 24346146
[TBL] [Abstract][Full Text] [Related]
118. Study of magnetic nanovectors by Wet-STEM, a new ESEM mode in transmission.
Maraloiu VA; Hamoudeh M; Fessi H; Blanchin MG
J Colloid Interface Sci; 2010 Dec; 352(2):386-92. PubMed ID: 20864114
[TBL] [Abstract][Full Text] [Related]
119. Targeting cancer cells: magnetic nanoparticles as drug carriers.
Alexiou C; Schmid RJ; Jurgons R; Kremer M; Wanner G; Bergemann C; Huenges E; Nawroth T; Arnold W; Parak FG
Eur Biophys J; 2006 May; 35(5):446-50. PubMed ID: 16447039
[TBL] [Abstract][Full Text] [Related]
120. Rattle-structured multifunctional nanotheranostics for synergetic chemo-/radiotherapy and simultaneous magnetic/luminescent dual-mode imaging.
Fan W; Shen B; Bu W; Chen F; Zhao K; Zhang S; Zhou L; Peng W; Xiao Q; Xing H; Liu J; Ni D; He Q; Shi J
J Am Chem Soc; 2013 May; 135(17):6494-503. PubMed ID: 23574400
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
